Liquid biopsy–based biomarkers for the characterization of hormone receptor-positive
Liquid biopsy–based biomarkers for the characterization of hormone receptor-positive (HR+) HER2-Low metastatic breast cancer (mBC)
https://www.annalsofoncology.org/art...151-2/fulltext
|